Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$306.88 - $380.0 $61,376 - $76,000
-200 Reduced 1.73%
11,355 $4.3 Million
Q3 2023

Oct 23, 2023

BUY
$315.92 - $397.36 $947,760 - $1.19 Million
3,000 Added 35.07%
11,555 $3.67 Million
Q2 2023

Aug 02, 2023

BUY
$346.15 - $392.09 $449,994 - $509,716
1,300 Added 17.92%
8,555 $3.28 Million
Q1 2023

May 15, 2023

SELL
$323.56 - $373.36 $1.23 Million - $1.42 Million
-3,800 Reduced 34.37%
7,255 $2.71 Million
Q4 2022

Feb 14, 2023

SELL
$248.67 - $334.17 $646,542 - $868,842
-2,600 Reduced 19.04%
11,055 $3.65 Million
Q2 2022

Aug 11, 2022

BUY
$301.4 - $428.42 $1.96 Million - $2.78 Million
6,500 Added 90.85%
13,655 $4.28 Million
Q1 2022

May 13, 2022

SELL
$379.46 - $424.54 $3.64 Million - $4.08 Million
-9,603 Reduced 57.3%
7,155 $2.99 Million
Q4 2021

Feb 15, 2022

SELL
$373.53 - $434.12 $410,882 - $477,532
-1,100 Reduced 6.16%
16,758 $7.02 Million
Q3 2021

Nov 15, 2021

SELL
$396.76 - $455.92 $674,492 - $775,064
-1,700 Reduced 8.69%
17,858 $7.38 Million
Q2 2021

Aug 12, 2021

SELL
$372.36 - $412.07 $37,236 - $41,207
-100 Reduced 0.51%
19,558 $7.75 Million
Q1 2021

May 17, 2021

BUY
$357.26 - $392.57 $571,616 - $628,112
1,600 Added 8.86%
19,658 $7.55 Million
Q4 2020

Feb 12, 2021

SELL
$319.05 - $363.32 $382,860 - $435,984
-1,200 Reduced 6.23%
18,058 $6.56 Million
Q3 2020

Nov 13, 2020

BUY
$280.08 - $347.78 $672,192 - $834,671
2,400 Added 14.24%
19,258 $6.49 Million
Q2 2020

Aug 13, 2020

BUY
$270.93 - $320.3 $541,860 - $640,600
2,000 Added 13.46%
16,858 $4.78 Million
Q1 2020

May 11, 2020

SELL
$243.44 - $359.98 $194,752 - $287,984
-800 Reduced 5.11%
14,858 $4.1 Million
Q4 2019

Feb 10, 2020

BUY
$281.18 - $322.05 $337,416 - $386,460
1,200 Added 8.3%
15,658 $5.03 Million
Q3 2019

Oct 31, 2019

SELL
$294.25 - $341.49 $268,356 - $311,438
-912 Reduced 5.93%
14,458 $4.29 Million
Q2 2019

Jul 17, 2019

BUY
$279.29 - $336.89 $223,432 - $269,512
800 Added 5.49%
15,370 $5.18 Million
Q1 2019

Apr 29, 2019

BUY
$246.18 - $297.25 $653,361 - $788,901
2,654 Added 22.27%
14,570 $4.32 Million
Q4 2018

Jan 31, 2019

SELL
$232.7 - $281.66 $488,670 - $591,486
-2,100 Reduced 14.98%
11,916 $3.03 Million
Q3 2018

Nov 09, 2018

SELL
$236.3 - $277.15 $67,109 - $78,710
-284 Reduced 1.99%
14,016 $3.89 Million
Q2 2018

Jul 12, 2018

BUY
$217.98 - $237.23 $186,154 - $202,594
854 Added 6.35%
14,300 $3.37 Million
Q1 2018

May 07, 2018

SELL
$218.74 - $251.43 $106,963 - $122,949
-489 Reduced 3.51%
13,446 $3.08 Million
Q4 2017

Feb 12, 2018

BUY
$217.88 - $244.43 $504,610 - $566,099
2,316 Added 19.93%
13,935 $3.04 Million
Q3 2017

Nov 07, 2017

SELL
$231.6 - $253.39 $14,127 - $15,456
-61 Reduced 0.52%
11,619 $2.76 Million
Q2 2017

Aug 08, 2017

BUY
N/A
11,680
11,680 $2.8 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Fjarde Ap Fonden Portfolio

Follow Fjarde Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.